| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 02/14/2002 | WO2002012221A1 Method for optical resolution of (±)-6-hydroxy-2,5,7,8-tetramethylcoumarone-2-carboxylic acid |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002011720A1 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures |
| 02/14/2002 | WO2002011707A2 Drugs for incontinence |
| 02/14/2002 | WO2002011563A1 Food supplement |
| 02/14/2002 | US20020019568 Novel process and intermediates |
| 02/14/2002 | US20020019538 Prevention binding of transcription factor tozinc finger binding compounds |
| 02/14/2002 | US20020019401 Psychological disorders; adjustment of dopamine concentration |
| 02/14/2002 | US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 02/14/2002 | US20020018912 Transistors, liquid crystal display, electrooptics |
| 02/14/2002 | US20020018807 Mixture of cocoa plant extract and antichloesterol agent |
| 02/14/2002 | US20020017451 Process for the preparation of tocol acylates and tocopherol acylates |
| 02/14/2002 | DE10038007A1 Neue Amino-und Amido-Diphenylether für Arzneimittel New amino and amido diphenyl ether for drugs |
| 02/14/2002 | DE10037846A1 Novel flavonoids with phenyl or heterocyclic substituents optionally bonded via unsaturated groups are useful as UV-absorbers and/or antioxidants in cosmetic or dermatological compositions |
| 02/14/2002 | CA2419066A1 Food supplement |
| 02/13/2002 | EP1179531A1 Intermediates for use in the preparation of vitamin E |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178791A2 The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders |
| 02/13/2002 | EP0743311B1 Flavanonol derivatives and hair nourishment and growth stimulant composition containing the same |
| 02/13/2002 | CN1335775A Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation and cyclooxygenase enzymes |
| 02/13/2002 | CN1335311A Malic polyphenol producing process with apple peel slag |
| 02/13/2002 | CN1335310A Gamma-pyronone and its synthesis and use |
| 02/13/2002 | CN1335309A New eka-favone and its application in preparation of cosmetic and dermatology |
| 02/13/2002 | CN1335292A Hairyleaf peudoyingzhaosu C as one compound with antineoplastic activity and its serial analogs |
| 02/13/2002 | CN1335157A Systemic separation process and prepn of ginkgetin, ginkgolide and bilobalide |
| 02/12/2002 | US6346626 Drugs for treatment of skin disorders such as acne, seborrhea, androgenic alopecia and hirsutism, or in the topical treatment of squamous cell carcinoma |
| 02/12/2002 | US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/07/2002 | WO2002010432A2 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/07/2002 | WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | WO2002009756A1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| 02/07/2002 | WO2002009734A1 Sugar absorption inhibitors and process for producing the same |
| 02/07/2002 | WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 02/07/2002 | US20020016478 Pretreating dry plant material by macerating in water |
| 02/07/2002 | US20020016365 Nonsteroidal gestagens |
| 02/07/2002 | US20020016360 Method of diminishing the adverse effects of interleukin-2 |
| 02/07/2002 | US20020016358 Cosmetic composition |
| 02/07/2002 | CA2417788A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/06/2002 | EP1178044A1 Tocopherylalkoxylates, their preparation and their use in cosmetic and pharmaceutical forms |
| 02/06/2002 | EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | CN1334802A Ligands of nuclear receptor |
| 02/05/2002 | US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/05/2002 | US6344531 Fluorescent water-soluble polymers |
| 02/05/2002 | US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis |
| 02/05/2002 | US6344463 Skin disorders, acne |
| 02/05/2002 | US6344454 Contraceptive preparations,treatment of endometriosis, gynecological disorders,premenstrual symptoms, male birth control, male hrt and hormone therapy and for treating andrological disease agents. |
| 02/05/2002 | US6344320 Electrophoresis of nascent proteins |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 01/31/2002 | WO2002008218A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 01/31/2002 | WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 01/31/2002 | WO2001070668A3 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 01/31/2002 | WO2001060832A3 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 01/31/2002 | US20020013497 Alkylation, blocking |
| 01/31/2002 | US20020013481 Use of flavones flavanones and flavonoids for protecting ascorbic acid and/or ascorbyl compounds from oxidation |
| 01/31/2002 | US20020013478 Viricides |
| 01/31/2002 | US20020013370 Methods for identifying and treating resistant tumors |
| 01/31/2002 | US20020013357 Valdecoxib compositions |
| 01/31/2002 | CA2415196A1 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds |
| 01/30/2002 | EP1175415A1 Synthetic methods for preparing procyanidin oligomers |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP0866791B1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 01/30/2002 | CN1333208A Process for preparing natural vitamin E monomester succinate |
| 01/29/2002 | US6342633 O-benzyl oxime ether derivatives and their use as pesticides |
| 01/29/2002 | US6342602 Bind specifically or selectively to rar-alpha receptors |
| 01/29/2002 | US6342510 Antiinflammatory agents and enzyme inhibitors |
| 01/29/2002 | US6342459 Photochromic naphthopyrans |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/29/2002 | CA2243363C Process for producing chromans |
| 01/29/2002 | CA2053477C Heterocyclic amine derivatives, their production and use |
| 01/24/2002 | WO2002006264A1 Lipid-rich plaque inhibitors |
| 01/24/2002 | WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | WO2002005812A1 Medicaments for chemotherapeutic treatment of disease |
| 01/24/2002 | WO2002005811A1 Stem cell reinforcing material |
| 01/24/2002 | WO2002005794A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 01/24/2002 | WO2001062781A3 Homogentisate phytyl transferase |
| 01/24/2002 | US20020010347 Preparation of d,l-alpha-tocopherol |
| 01/24/2002 | US20020010322 New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments |
| 01/24/2002 | US20020010288 Copper clad laminates |
| 01/24/2002 | US20020010213 Inhibiting membrane transport mediated by the multidrug resistance associated protein MRP in a patient by administering a compound having an amphiphilic anion and a molecular weight of from 300 to 950 daltons. |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010195 Mitochondria protecting agents for treating mitochondria associated diseases |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | US20020009635 Novel materials for use as electrolytic solutes |
| 01/24/2002 | DE10033459A1 New aminomethyl-substituted bicyclic compounds, useful for treating urinary incontinence, pruritis, tinnitus, diarrhea or especially pain |
| 01/24/2002 | DE10033016A1 Verfahren zur Herstellung von 3,3-Diarylpropylaminen A process for the preparation of 3,3-Diarylpropylaminen |
| 01/24/2002 | CA2429008A1 Lipid-rich plaque regressing agents |
| 01/24/2002 | CA2415896A1 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 01/24/2002 | CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | CA2377666A1 Stem cell reinforcing material |
| 01/23/2002 | EP1174144A1 Dry extract rich in isoflavones and process of preparation |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173164A2 Estrogen receptor-beta ligands |
| 01/23/2002 | EP0877091B1 Antifungal substances be-49385 and process for producing the same |
| 01/23/2002 | CN1332164A Acidylation method |
| 01/22/2002 | US6340766 Photochromic dyes on substrates like glass with protective coatings |